InvestSMART

Mayne Pharma Group Limited (ASX: MYX) - Announcements

Current share price for MYX : $2.450 0.04 (1.61%)+

ASX company news and announcements for Mayne Pharma Group Limited (MYX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mayne Pharma Group Limited (MYX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mayne Pharma Group Limited (MYX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mayne Pharma Group Limited (MYX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$201 Doryx Generic Update 22 Sep 2011 10:07AM $0.370 $2.450 risen by 562.16%
$201 FDA Approval Of New Dual-Scored 150mg Doryx Tablet 14 Sep 2011 4:52PM $0.440 $2.450 risen by 456.82%
$201 Preliminary Final Report 31 Aug 2011 1:47PM $0.375 $2.450 risen by 553.33%
$201 Mayne Pharma Market Update 5 Jul 2011 12:10PM $0.400 $2.450 risen by 512.50%
$201 Mayne Pharma Market Update 15 Jun 2011 4:33PM $0.400 $2.450 risen by 512.50%
$201 Half Yearly Report and Accounts 25 Feb 2011 5:08PM $0.510 $2.450 risen by 380.39%
$201 Future Cash Flow Reporting 1 Feb 2011 10:39AM $0.900 $2.450 risen by 172.22%
$201 Appendix 4C - quarterly 28 Oct 2010 4:32PM $0.720 $2.450 risen by 240.28%

901 - 908 of 908 results

Page 37 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.